Ca2+, calmodulin, and cyclins in vascular smooth muscle cell cycle

Circulation Research

Volumn 98, Issue 10, 2006, Pages 1240-1243

  Koledova, Vera V ^a   Khalil, Raouf A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN II; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL; CALCIUM ION; CALMIDAZOLIUM; CALMODULIN; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN; MYOSIN LIGHT CHAIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATASE; PHOSPHODIESTERASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1; CALCIUM;

ATHEROSCLEROSIS; BLOOD VESSEL TONE; CALCIUM TRANSPORT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DEATH; CELL GROWTH; CORONARY ARTERY SPASM; DEPHOSPHORYLATION; DNA SYNTHESIS; EDITORIAL; FERTILIZATION; GLYCOSYLATION; HYPERLIPIDEMIA; HYPERTENSION; HYPOXIA; MAMMAL CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; RESTENOSIS; SARCOPLASMIC RETICULUM; SECOND MESSENGER; SMOKING; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; CYTOLOGY; HUMAN; METABOLISM; NOTE; PHYSIOLOGY;

ANIMALS; CALCIUM; CALMODULIN; CELL CYCLE; CYCLINS; HUMANS; MUSCLE, SMOOTH, VASCULAR;

EID: 33745006646     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000225860.41648.63     Document Type: Editorial

References (42)

1. 2+ signaling. Cell Mol Life Sci. 2005;62:2405-2413.
2. Khalil RA, van Breemen C. Mechanisms of calcium mobilization and homeostasis in vascular smooth muscle and their relevance to hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press; 1995:523-540.
3. Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev. 1996;76:967-1003.
4. 2+ oscillations, gradients, and homeostasis in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2002;282:H1571-H1583.
5. Cain AE, Khalil RA. Pathophysiology of essential hypertension: role of the pump, the vessel, and the kidney. Semin Nephrol. 2002;22:3-16.
6. Salamanca DA, Khalil RA. Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem Pharmacol. 2005;70:1537-1547.
7. Hirabayashi T, Murayama T, Shimizu T. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharm Bull. 2004;27:1168-1173.
8. 2+-calmodulin-dependent phosphodiesterase (PDE1): current perspectives. Cell Signal. 2005;17:789-797.
9. Ledoux J, Werner ME, Brayden JE, Nelson MT. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda). 2006;21:69-78.
10. Guerini D, Coletto L, Carafoli E. Exporting calcium from cells. Cell Calcium. 2005;38:281-289.
11. 2+. Cell Calcium. 2002;32:321-334.
12. 2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium. 2005;38:291-302.
13. 2+/calmodulin-dependent protein kinase II from smooth muscle. Biochem J. 1995;310:517-525.
14. 2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta. J Physiol. 2000;526:367-374.
15. Pfleiderer PJ, Lu KK, Crow MT, Keller RS, Singer HA. Modulation of vascular smooth muscle cell migration by calcium/calmodulin-dependent protein kinase II-delta 2. Am J Physiol Cell Physiol. 2004;286:C1238-C1245.
16. Pfitzer G. Invited review: regulation of myosin phosphorylation in smooth muscle. J Appl Physiol. 2001;91:497-503.
17. Zahradka P, Werner JP, Buhay S, Litchie B, Helwer G, Thomas S. NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. J Mol Cell Cardiol. 2002;34:1609-1621.
18. Kintscher U, Bruemmer D, Blaschke F, Unger T, Law RE. p38 MAP kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cells. Biochem Biophys Res Commun. 2003;305:552-556.
19. Zhang YM, Wang KQ, Zhou GM, Zuo J, Ge JB. Endothelin-1 promoted proliferation of vascular smooth muscle cell through pathway of extracellular signal-regulated kinase and cyclin D1. Acta Pharmacol Sin. 2003;24:563-568.
20. Pestana IA, Vazquez-Padron RI, Aitouche A, Pham SM. Nicotinic and PDGF-receptor function are essential for nicotine-stimulated mitogenesis in human vascular smooth muscle cells. J Cell Biochem. 2005;96:986-995.
21. Schultz K, Fanburg BL, Beasley D. Hypoxia and hypoxia-inducible factor-1{alpha} promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. In press.
22. Taylor AM, Li F, Thimmalapura P, Gerrity RG, Sarembock IJ, Forrest S, Rutherford S, McNamara CA. Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3. J Vasc Res. 2006;43:123-130.
23. Lin SJ, Shyue SK, Shih MC, Chu TH, Chen YH, Ku HH, Chen JW, Tam KB, Chen YL. Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors. Atherosclerosis. In press.
24. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38:581-587.
25. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev. 2001;81:999-1030.
26. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
27. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/ calmodulin-dependent pathways. Endocr Rev. 2003;24:719-736.
28. Kortvely E, Gulya K. Calmodulin, and various ways to regulate its activity. Life Sci. 2004;74:1065-1070.
29. Boehm M, Nabel EG. The cell cycle and cardiovascular diseases. Prog Cell Cycle Res. 2003;5:19-30.
30. Yang M, Huang HL, Zhu BY, Tuo QH, Liao DF. Onychin inhibits proliferation of vascular smooth muscle cells by regulating cell cycle. Acta Pharmacol Sin. 2005;26:205-211.
31. Shukla N, Rowe D, Hinton J, Angelini GD, Jeremy JY. Calcium and the replication of human vascular smooth muscle cells: studies on the activation and translocation of extracellular signal regulated kinase (ERK) and cyclin D1 expression. Eur J Pharmacol. 2005;509:21-30.
32. 2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ Res. 2005;97:488-495.
33. 2+-sensitive G1/S transitions in vascular smooth muscle cells. Circ Res. 2006;98:1273-1281.
34. 2+-sensitive ion channels. Cell Calcium. 2003;34:211-229.
35. 2+/calmodulin- stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival. Circ Res. 2006;98:777-784.
36. Benaim G, Villalobo A. Phosphorylation of calmodulin: functional implications. Eur J Biochem. 2002;269:3619-3631.
37. Okamoto K, Kato S, Arima N, Fujii T, Morimatsu M, Imaizumi T. Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy. Hypertens Res. 2004;27:283-291.
38. Nakano N, Urasawa K, Takagi Y, Saito T, Kaneta S, Ishikawa S, Higashi H, Tsutsui H, Hatakeyama M, Kitabatake A. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells. Biochem Biophys Res Commun. 2005;338:1661-1667.
39. Gizard F, Amant C, Barbier O, Bellosta S, Robillard R, Percevault F, Sevestre H, Krimpenfort P, Corsini A, Rochette J, Glineur C, Fruchart JC, Torpier G, Staels B. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a. J Clin Invest. 2005;115:3228-3238.
40. 2+-regulated transcriptional repressor. Nature. 1999;398:80-84.
41. Ikura M, Osawa M, Ames JB. The role of calcium-binding proteins in the control of transcription: structure to function. Bioessays. 2002;24:625-636.
42. Touyz RM, Yao G. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. J Cell Physiol. 2003;197:326-335.